Effects of soy protein on lipoprotein lipids and fecal bile acid excretion in men and women with moderate hypercholesterolemia

Journal of Clinical Lipidology

Volumn 4, Issue 6, 2010, Pages 531-542

  Maki, Kevin C ^a   Butteiger, Dustie N ^b   Rains, Tia M ^a   Lawless, Andrea ^a   Reeves, Matthew S ^a   Schasteen, Chuck ^b   Krul, Elaine S ^b  

^a Provident Clinical Research and Consulting Inc   (United States)

^b Solae LLC   (United States)

Author keywords

Dairy protein; Fecal bile acids; Lipoprotein lipids; Soy protein

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BILE ACID; CALCIUM; COLESEVELAM; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVALONIC ACID; MILK PROTEIN; SITOSTEROL; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ENERGY; FECES ANALYSIS; FEMALE; HUMAN; HYDROLYSIS; HYPERCHOLESTEROLEMIA; LIFESTYLE MODIFICATION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ALLYLAMINE; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEINS B; BILE ACIDS AND SALTS; CHOLESTEROL; CHOLESTEROL, LDL; DIETARY FATS; FECES; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS; MALE; MEVALONIC ACID; MIDDLE AGED; SOYBEAN PROTEINS;

EID: 78649660818     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2010.09.001     Document Type: Article

References (57)

1. E. Dembowski, and M.H. Davidson A review of lipid management in primary and secondary prevention J Cardiopulm Rehabil Prev 29 2009 2 12
2. S.M. Grundy, J.I. Cleeman, C.N. Merz Coordinating Committee of the National Cholesterol Education Program Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines J Am Coll Cardiol 44 2004 720 732
3. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486-2427
4. A.M. Gotto Jr. Contemporary Diagnosis and Management of Lipid Disorders 4th ed 2008 Handbooks in Health Care Co., a Division of AMM Co.; Inc. Newton, PA
5. A.M. Hill, J.A. Fleming, and P.M. Kris-Etherton The role of diet and nutritional supplements in preventing and treating cardiovascular disease Curr Opin Cardiol 24 2009 433 441
6. J.G. Robinson, S. Wang, B.J. Smith, and T.A. Jacobson Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk J Am Coll Cardiol 53 2009 316 322
7. Appel LJ, Sacks FM, Carey VJ, et al., OmniHeart Collaborative Research Group. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA. 200516;294:2455-2464.
8. B.M. Wolfe, and L.A. Piché Replacement of carbohydrate by protein in a conventional-fat diet reduces cholesterol and triglyceride concentrations in healthy normolipidemic subjects Clin Invest Med 22 1999 140 148
9. F.M. Sacks, A. Lichtenstein, L. Van Horn, W. Harris, P. Kris-Etherton, and M. Winston Soy protein, isoflavones, and cardiovascular health. An American Heart Association Science Advisory for Professionals from the Nutrition Committee Circulation 113 2006 1034 1044 (Pubitemid 43879479)
10. J.W. Anderson, B.M. Johnstone, and M.E. Cook-Newell Meta-analysis of the effects of soy protein intake on serum lipids N Engl J Med 333 1995 276 282
11. S. Zhan, and S.C. Ho Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile Am J Clin Nutr 81 2005 397 408
12. M.W. Huff, and K.K. Carroll Effects of dietary protein on turnover, oxidation, and absorption of cholesterol and on steroid excretion in rabbits J Lipid Res 21 1980 546 559
13. A.C. Beynen Comparison of the mechanism proposed to explain the hypocholesterolemic effect of soybean protein versus casein in experimental animals J Nutr Sci Vitaminol 36 1990 S87 S93
14. N. Torres, I. Torre-Villalvazo, and A.R. Tovar Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders J Nutr Biochem 17 2006 365 373
15. S.M. Potter Overview of proposed mechanisms for the hypocholesterolemic effect of soy J Nutr 125 1995 606S 611S
16. S.J. Cho, M.A. Juillerat, and C.H. Lee Identification of LDL-receptor transcription stimulating peptides from soybean hydrolysate in human hepatocytes J Agric Food Chem 56 2008 4372 4376
17. M.H. Davidson The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review Expert Opin Pharmacother 8 2007 2569 2578
18. K. Iwami, K. Sakakibara, and F. Ibuki Involvement of post-digestion 'hydrophobic' peptides in plasma cholesterol-lowering effect of dietary plant proteins Agric Biol Chem 50 1986 1217 1222
19. M. Sugano, S. Goto, and Y. Yamada Cholesterol-lowering activity of various undigested fractions of soybean protein in rats J Nutr 120 1990 977 985
20. N. Higaki, K. Sato, and H. Suda Evidence for the existence of a soybean resistant protein that captures bile acid and stimulates its fecal excretion Biosci Biotechnol Biochem 70 2006 2844 2852
21. F.M. Sacks, J.L. Breslow, and P.G. Wood Lack of an effect of diary protein (casein) and soy protein on plasma cholesterol of strict vegetarians: an experiment and a critical review J Lipid Res 24 1983 1012 1020
22. D.W. Harsha, F.M. Sacks, and E. Obarzanek Effect of dietary sodium intake on blood lipids: results from the DASH-sodium trial Hypertension 43 2004 393 398
23. E. Obarzanek, F.M. Sacks, W.M. Vollmer DASH Research Group Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial Am J Clin Nutr 74 2001 80 99
24. R.M. Bostick, L. Fosdick, G.A. Grandits, P. Grambsch, M. Gross, and T.A. Louis Effect of calcium supplementation on serum cholesterol and blood pressure. A randomized, double-blind, placebo-controlled, clinical trial Arch Fam Med 9 2000 31 39
25. G.C. Major, F. Alarie, J. Doré, S. Phouttama, and A. Tremblay Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations Am J Clin Nutr 85 2007 54 59
26. Food labeling: health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule Fed Regist 64 1999 57700 57733
27. H.H. Knapp, H. Schrott, and P. Ma Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia Am J Med 110 2001 352 360 (Pubitemid 32248724)
28. WelChol® (colesevelam hydrochloride) Prescribing Information 2010 Daiichi Sankyo, Inc Tokyo, Japan
29. P.M. Kris-Etherton, and J. Dietschy Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors: human and animal studies Am J Clin Nutr 65 1997 1590S-1569S
30. D.J. Jenkins, J.M. Wong, and C.W. Kendall The effect of a plant-based low-carbohydrate ("Eco-Atkins") diet on body weight and blood lipid concentrations in hyperlipidemic subjects Arch Intern Med 169 2009 1046 1054
31. R.P. Mensink, S. Ebbing, M. Lindhout, J. Plat, and M.M. van Heugten Effects of plant stanol esters supplied in low-fat yoghurt on serum lipids and lipoproteins, non-cholesterol sterols and fat soluble antioxidant concentrations Atherosclerosis 160 2002 205 213
32. Food and Drug Administration, HHS Food labeling: health claims; soluble dietary fiber from certain foods and coronary heart disease. Proposed rule Fed Regist 62 1997 28234 28245
33. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of LDL cholesterol in plasma without use of preparative ultracentrifuge Clin Chem 18 1972 499 502
34. S. Perwaiz, B. Tuchweber, D. Mignault, T. Gilat, and I.M. Yousef Determination of bile acids in biological fluids by liquid chromatography- electrospray tandem mass spectrometry J Lipid Res 42 2001 114 119
35. P.J. Gillies, J.T. Billheimer, and V.A. Blackston DMP 504, a novel hydrogel bile acid sequestrant: II. Lipid-lowering pharmacology in the hamster Drug Develop Res 44 1997 65 75
36. ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group Stat Med 18 1999 1905 1942
37. S. Yu, J. Derr, T.D. Etherton, and P.M. Kris-Etherton Plasma cholesterol-predictive equations demonstrate that stearic acid is neutral and monounsaturated fatty acids are hypocholesterolemic Am J Clin Nutr 61 1995 1129 1139
38. J.I. Harland, and T.A. Haffner Systematic review, meta-analysis and regression of randomized controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol Atherosclerosis 200 2008 13 27
39. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
40. B.G. Brown, K.H. Stukovsky, and X.Q. Zhao Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials Curr Opin Lipidol 17 2006 631 636
41. R. Fumagalli, L. Soleri, and R. Farini Fecal cholesterol excretion studies in type II hypercholesterolemic patients treated with soybean protein diet Atherosclerosis 43 1982 341 353
42. E. Roda, G. Mazzella, G.L. Cornia, N. Villanova, L. Pironi, and L. Barbara (1983) Effects of soybean protein rich diet on biliary lipid composition L. Barbara, M. Miglioli, S.F. Phillips, New Trends in Pathophysiology and Therapy of the Large Bowel 1983 Elsevier/North Holland Biochemical Press Amsterdam, The Netherlands 309 312
43. M.S. Anthony, T.B. Clarkson, and J.K. Williams Effects of soy isoflavones on atherosclerosis: potential mechanisms Am J Clin Nutr 68 1998 1390S 1393S
44. J.R. Crouse, T. Morgan, J.G. Terry, J. Ellis, M. Vitolins, and G.L. Burke A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins Arch Intern Med 159 1999 2070 2076
45. R.M. Weggemans, and E.A. Trautwein Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis Eur J Clin Nutr 57 2003 940 946
46. B.L. McVeigh, B.L. Dillingham, J.W. Lampe, and A.M. Duncan Effect of soy protein varying in isoflavone content on serum lipids in healthy young men Am J Clin Nutr 83 2006 244 251
47. K. Taku, K. Umegaki, Y. Ishimi, and S. Watanabe Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: meta-analysis of randomized controlled trials Ther Clin Risk Manag 4 2008 1097 1103
48. M. Duranti, M.R. Lovati, and V. Dani The α′ subunit from soybean 7S globulin lowers plasma lipids and upregulates liver β-VLDL receptors in rats fed a hypercholesterolemic diet J Nutr 134 2004 1334 1339
49. F. Zhong, X. Zhang, J. Na, and C.F. Shoemaker Fractionation and identification of a novel hypocholesterolemic peptide derived from soy protein Alcalase hydrolysates Food Res Int 40 2007 756 762
50. I.R. Reid, R. Ames, and B. Mason Effects of calcium supplementation on lipids, blood pressure, and body composition in healthy older men: a randomized controlled trial Am J Clin Nutr 91 2010 131 139
51. M.A. Denke, M.M. Fox, and M.C. Schulte Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men J Nutr 123 1993 1047 1053
52. I.R. Reid Effects of calcium supplementation on circulating lipids: potential pharmacoeconomic implications Drugs Aging 21 2004 7 17
53. E. Balk, M. Chung, and P. Chew Effects of soy on health outcomes. Evidence report/technology assessment No. 126 (prepared by Tufts-New England Medical Center Evidence-based Practice Center under Contract No. 290-02-0022.) AHRQ Publication No. 05-E024-2 2005 Agency for Healthcare Research and Quality Rockville, MD
54. D.J. Jenkins, C.W. Kendall, and C.J. Jackson Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women Am J Clin Nutr 76 2002 365 372
55. J. Davis, A. Higginbotham, and T. O'Connor Soy protein and isoflavones influence adiposity and development of metabolic syndrome in the obese male ZDF rat Ann Nutr Metab 51 2007 42 52
56. M.J. Ronis, Y. Chen, J. Badeaux, and T.M. Badger Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR and SREBP signaling J Nutr 139 2009 1431 1438
57. A. Tovar, and N. Torres The role of dietary protein on lipotoxicity Biochim Biophys Acta 1801 2010 367 371